Nicotine delivery to the aerosol of a heat-not-burn tobacco product: Comparison with a tobacco cigarette and e-cigarettes

Nicotine and Tobacco Research

Volumn 20, Issue 8, 2018, Pages 1004-1009

  Farsalinos, Konstantinos E ^a,b   Yannovits, Nikoletta ^c   Sarri, Theoni ^c   Voudris, Vassilis ^a   Poulas, Konstantinos ^b  

^a ONASSIS CARDIAC SURGERY CENTER   (Greece)

^b UNIVERSITY OF PATRAS   (Greece)

^c Skylab Med Laboratories of Applied Industrial Research and Analysis SA   (Greece)

Author keywords

[No Author keywords available]

Indexed keywords

MENTHOL; NICOTINE;

AEROSOL; ARTICLE; CIGARETTE SMOKING; DEVICE COMPARISON; DEVICE SAFETY; HARM REDUCTION; HEAT NOT BURN TOBACCO PRODUCT; PRIORITY JOURNAL; TOBACCO; TOBACCO DEPENDENCE; VAPING; ADMINISTRATION AND DOSAGE; COMPARATIVE STUDY; DEVICES; ELECTRONIC CIGARETTE; HEAT; HUMAN; PROCEDURES;

AEROSOLS; ELECTRONIC NICOTINE DELIVERY SYSTEMS; HARM REDUCTION; HOT TEMPERATURE; HUMANS; NICOTINE; TOBACCO PRODUCTS;

EID: 85054305240     PISSN: 14622203     EISSN: 1469994X     Source Type: Journal    
DOI: 10.1093/ntr/ntx138     Document Type: Article

References (37)

1. Benowitz NL, Hukkanen J, Jacob P 3rd. Nicotine chemistry, metabolism, kinetics and biomarkers. Handb Exp Pharmacol. 2009;192:29-60.
2. Nakamura M, Oshima A, Fujimoto Y, Maruyama N, Ishibashi T, Reeves KR. Efficacy and tolerability of varenicline, an alpha4beta2 nicotinic acetylcholine receptor partial agonist, in a 12-week, randomized, placebocontrolled, dose-response study with 40-week follow-up for smoking cessation in Japanese smokers. Clin Ther. 2007;29(6):1040-1056.
3. Rigotti NA, Pipe AL, Benowitz NL, Arteaga C, Garza D, Tonstad S. Efficacy and safety of varenicline for smoking cessation in patients with cardiovascular disease: a randomized trial. Circulation. 2010;121(2):221-229.
4. West R, Stapleton J. Clinical and public health significance of treatments to aid smoking cessation. Europ Respir Rev. 2008;17(110):199-204.
5. Farsalinos KE, Romagna G, Tsiapras D, Kyrzopoulos S, Voudris V. Evaluating nicotine levels selection and patterns of electronic cigarette use in a group of "vapers" who had achieved complete substitution of smoking. Subst Abuse. 2013;7:139-146.
6. Farsalinos KE, Spyrou A, Tsimopoulou K, Stefopoulos C, Romagna G, Voudris V. Nicotine absorption from electronic cigarette use: comparison between first and new-generation devices. Sci Rep. 2014;4:4133.
7. Nides MA, Leischow SJ, Bhatter M, Simmons M. Nicotine blood levels and short-term smoking reduction with an electronic nicotine delivery system. Am J Health Behav. 2014;38(2):265-274.
8. Farsalinos KE, Yannovits N, Sarri T, Voudris V, Poulas K. Protocol proposal for, and evaluation of, consistency in nicotine delivery from the liquid to the aerosol of electronic cigarettes atomizers: regulatory implications. Addiction. 2016;111(6):1069-1076.
9. Goniewicz ML, Hajek P, McRobbie H. Nicotine content of electronic cigarettes, its release in vapour and its consistency across batches: regulatory implications. Addiction. 2014;109(3):500-507.
10. Dawkins LE, Kimber CF, Doig M, Feyerabend C, Corcoran O. Selftitration by experienced e-cigarette users: blood nicotine delivery and subjective effects. Psychopharmacology (Berl). 2016;233(15-16):2933-2941.
11. Spindle TR, Breland AB, Karaoghlanian NV, Shihadeh AL, Eissenberg T. Preliminary results of an examination of electronic cigarette user puff topography: the effect of a mouthpiece-based topography measurement device on plasma nicotine and subjective effects. Nicotine Tob Res. 2015;17(2):142-149.
12. Hajek P, Przulj D, Phillips A, Anderson R, McRobbie H. Nicotine delivery to users from cigarettes and from different types of e-cigarettes. Psychopharmacology (Berl). 2017;234(5):773-779.
13. Sutherland G, Russell MA, Stapleton JA, Feyerabend C. Glycerol particle cigarettes: a less harmful option for chronic smokers. Thorax. 1993;48(4):385-387.
14. Woodson PP, Fagerstrom KO, Molander L, Slade J, Henningfeld JE. Premier: a new nicotine delivery system-studies on its environmental and biological impact. J Smoking-Related Dis 1993;4(3):191-201.
15. Stapleton JA, Russell MA, Sutherland G, Feyerabend C. Nicotine availability from Eclipse tobacco-heating cigarette. Psychopharmacology (Berl). 1998;139(3):288-290.
16. RJ Reynolds Records. Premier Consumer Research Overview. https://www.industrydocumentslibrary.ucsf.edu/tobacco/docs/#id=nrmk0084. Accessed November 4, 2016.
17. Anderson SJ, Ling PM. "And they told two friends...and so on:" RJ Reynolds' viral marketing of Eclipse and its potential to mislead the public. Tob Control. 2008;17(4):222-229.
18. Slade J, Connolly GN, Lymperis D. Eclipse: does it live up to its health claims? Tob Control. 2002;11(suppl 2):ii64-ii70.
19. Fagerström KO, Hughes JR, Rasmussen T, Callas PW. Randomised trial investigating effect of a novel nicotine delivery device (Eclipse) and a nicotine oral inhaler on smoking behaviour, nicotine and carbon monoxide exposure, and motivation to quit. Tob Control. 2000;9(3):327-333.
20. Foy JW, Bombick BR, Bombick DW, Doolittle DJ, Mosberg AT, Swauger JE. A comparison of in vitro toxicities of cigarette smoke condensate from Eclipse cigarettes and four commercially available ultra low-"tar" cigarettes. Food Chem Toxicol. 2004;42(2):237-243.
21. Doolittle DJ, Lee CK, Ivett JL, et al. Comparative studies on the genotoxic activity of mainstream smoke condensate from cigarettes which burn or only heat tobacco. Environ Mol Mutagen. 1990;15(2):93-105.
22. Swauger JE. Eclipse: does it live up to its health claims? Tob Control. 2003;12(1):104-105; author reply 105.
23. Smith MR, Clark B, Lüdicke F, et al. Evaluation of the tobacco heating system 2.2. Part 1: description of the system and the scientific assessment program. Regul Toxicol Pharmacol. 2016;81(suppl 2): S17-S26.
24. van der Toorn M, Frentzel S, De Leon H, Goedertier D, Peitsch MC, Hoeng J. Aerosol from a candidate modified risk tobacco product has reduced effects on chemotaxis and transendothelial migration compared to combustion of conventional cigarettes. Food Chem Toxicol. 2015;86:81-87.
25. Baker RR. Temperature distribution inside a burning cigarette. Nature 1974;247:405-406.
26. Schaller JP, Keller D, Poget L, et al. Evaluation of the tobacco heating system 2.2. Part 2: chemical composition, genotoxicity, cytotoxicity, and physical properties of the aerosol. Regul Toxicol Pharmacol. 2016;81(suppl 2):S27-S47.
27. Phillips B, Veljkovic E, Boué S, et al. An 8-month systems toxicology inhalation/cessation study in apoe-/-mice to investigate cardiovascular and respiratory exposure effects of a candidate modified risk tobacco product, ths 2.2, compared with conventional cigarettes. Toxicol Sci. 2016;149(2):411-432.
28. Haziza C, de La Bourdonnaye G, Skiada D, et al. Evaluation of the tobacco heating system 2.2. Part 8: 5-day randomized reduced exposure clinical study in Poland. Regul Toxicol Pharmacol. 2016;81(suppl 2):S139-S15.
29. Talih S, Balhas Z, Eissenberg T, et al. Effects of user puff topography, device voltage, and liquid nicotine concentration on electronic cigarette nicotine yield: measurements and model predictions. Nicotine Tob Res. 2015;17(2):150-157.
30. WHO. TobLabNet Official Method SOP 04. Standard Operating Procedure for Determination of Nicotine in Cigarette Tobacco Filler; 2014. http://apps.who.int/iris/bitstream/10665/102318/1/9789241503907-eng.pdf. Accessed May 4, 2017.
31. ICH Harmonised Tripartite Guideline. Validation of Analytical Procedures: Text and Methodology Q2 (R1); 2005. https://www.ich.org/fileadmin/Public-Web-Site/ICH-Products/Guidelines/Quality/Q2-R1/Step4/Q2-R1-Guideline.pdf. Accessed May 4, 2017.
32. Stepanov I, Hecht SS, Mirvish SS, Gonta M. Comparative analysis of tobacco-specific nitrosamines and total N-nitroso compounds in moldovan cigarette tobacco. J Agric Food Chem. 2005;53(20):8082-8086.
33. Farsalinos KE, Voudris V, Poulas K. E-cigarettes generate high levels of aldehydes only in 'dry puff' conditions. Addiction. 2015;110(8):1352-1356.
34. Farsalinos KE, Romagna G, Tsiapras D, Kyrzopoulos S, Voudris V. Evaluation of electronic cigarette use (vaping) topography and estimation of liquid consumption: implications for research protocol standards definition and for public health authorities' regulation. Int J Environ Res Public Health. 2013;10(6):2500-2514.
35. Hua M, Yip H, Talbot P. Mining data on usage of electronic nicotine delivery systems (ENDS) from YouTube videos. Tob Control. 2013;22(2):103-106.
36. Farsalinos KE, Spyrou A, Stefopoulos C, et al. Nicotine absorption from electronic cigarette use: comparison between experienced consumers (vapers) and naïve users (smokers). Sci Rep. 2015;5:11269.
37. Picavet P, Haziza C, Lama N, Weitkunat R, Lüdicke F. Comparison of the pharmacokinetics of nicotine following single and ad libitum use of a tobacco heating system or combustible cigarettes. Nicotine Tob Res. 2016;18(5):557-563.